Lantern Pharma Inc.
NASDAQ:LTRN

Watchlist Manager
Lantern Pharma Inc. Logo
Lantern Pharma Inc.
NASDAQ:LTRN
Watchlist
Price: 3.5101 USD -0.56% Market Closed
Market Cap: 37.8m USD
Have any thoughts about
Lantern Pharma Inc.?
Write Note

Lantern Pharma Inc.
Pre-Tax Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Lantern Pharma Inc.
Pre-Tax Income Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Pre-Tax Income Analysis
Latest Figures & CAGR of Competitors

Company Pre-Tax Income CAGR 3Y CAGR 5Y CAGR 10Y
Lantern Pharma Inc.
NASDAQ:LTRN
Pre-Tax Income
-$16m
CAGR 3-Years
-39%
CAGR 5-Years
-56%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Pre-Tax Income
$7.2B
CAGR 3-Years
0%
CAGR 5-Years
19%
CAGR 10-Years
4%
Gilead Sciences Inc
NASDAQ:GILD
Pre-Tax Income
$176m
CAGR 3-Years
-73%
CAGR 5-Years
-47%
CAGR 10-Years
-34%
Amgen Inc
NASDAQ:AMGN
Pre-Tax Income
$4.7B
CAGR 3-Years
-10%
CAGR 5-Years
-13%
CAGR 10-Years
-1%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Pre-Tax Income
$259.6m
CAGR 3-Years
-54%
CAGR 5-Years
-19%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Pre-Tax Income
$5B
CAGR 3-Years
-15%
CAGR 5-Years
18%
CAGR 10-Years
21%

See Also

What is Lantern Pharma Inc.'s Pre-Tax Income?
Pre-Tax Income
-16m USD

Based on the financial report for Dec 31, 2023, Lantern Pharma Inc.'s Pre-Tax Income amounts to -16m USD.

What is Lantern Pharma Inc.'s Pre-Tax Income growth rate?
Pre-Tax Income CAGR 5Y
-56%

Over the last year, the Pre-Tax Income growth was -12%. The average annual Pre-Tax Income growth rates for Lantern Pharma Inc. have been -39% over the past three years , -56% over the past five years .

Back to Top